Form EFFECT CATALYST PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 |
| Accession Number: | 0001193125-26-305097 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NCLA Urges Supreme Court to Hear Vaccine Mandate Case that Clearly Misreads Precedent
- TekSynap Appoints Richard Leino as Vice President of Solutions Architecture
- LACI Announces Nearly $600 Million in New Commitments to Action at Road to 2028 Summit; Commitments will Improve Air Quality and Economic Opportunity Through Clean Energy, Transportation Electrificati
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
